These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12498711)

  • 1. p53: regular or super?
    Roussel MF
    Cancer Cell; 2002 Dec; 2(6):434-5. PubMed ID: 12498711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer: super p53.
    Marte B
    Nature; 2002 Nov; 420(6913):279. PubMed ID: 12447427
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
    Johnson TM; Attardi LD
    Cell Death Differ; 2006 Jun; 13(6):902-8. PubMed ID: 16557272
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming.
    Ong ALC; Ramasamy TS
    Ageing Res Rev; 2018 May; 43():64-80. PubMed ID: 29476819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 isoforms regulate premature aging in human cells.
    von Muhlinen N; Horikawa I; Alam F; Isogaya K; Lissa D; Vojtesek B; Lane DP; Harris CC
    Oncogene; 2018 May; 37(18):2379-2393. PubMed ID: 29429991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aging or tumor: the crosstalk between telomerase and p53].
    Zhang XF; Tang WR; Luo Y
    Yi Chuan; 2009 May; 31(5):451-6. PubMed ID: 19586837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppression by p53 without accelerated aging: just enough of a good thing?
    Mendrysa SM; Perry ME
    Cell Cycle; 2006 Apr; 5(7):714-7. PubMed ID: 16582632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunction of the MDM2/p53 axis is linked to premature aging.
    Lessel D; Wu D; Trujillo C; Ramezani T; Lessel I; Alwasiyah MK; Saha B; Hisama FM; Rading K; Goebel I; Schütz P; Speit G; Högel J; Thiele H; Nürnberg G; Nürnberg P; Hammerschmidt M; Zhu Y; Tong DR; Katz C; Martin GM; Oshima J; Prives C; Kubisch C
    J Clin Invest; 2017 Oct; 127(10):3598-3608. PubMed ID: 28846075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The price of tumour suppression?
    Ferbeyre G; Lowe SW
    Nature; 2002 Jan; 415(6867):26-7. PubMed ID: 11780097
    [No Abstract]   [Full Text] [Related]  

  • 10. The p53 inducing drug dosage may determine quiescence or senescence.
    Lane DP; Verma C; Fang CC
    Aging (Albany NY); 2010 Nov; 2(11):748. PubMed ID: 21068468
    [No Abstract]   [Full Text] [Related]  

  • 11. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.
    Schmitt CA; Fridman JS; Yang M; Lee S; Baranov E; Hoffman RM; Lowe SW
    Cell; 2002 May; 109(3):335-46. PubMed ID: 12015983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of the p53-MDM2 axis to aging.
    Wu D; Prives C
    Cell Death Differ; 2018 Jan; 25(1):169-179. PubMed ID: 29192902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trapping cells in senescence with a lamin cage.
    Cordero G; D'Amours D
    Cell Cycle; 2015; 14(17):2725-6. PubMed ID: 26237172
    [No Abstract]   [Full Text] [Related]  

  • 14. Desumoylase SENP6 maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway.
    Li J; Lu D; Dou H; Liu H; Weaver K; Wang W; Li J; Yeh ETH; Williams BO; Zheng L; Yang T
    Nat Commun; 2018 Jan; 9(1):143. PubMed ID: 29321472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutant mice that display early ageing-associated phenotypes.
    Tyner SD; Venkatachalam S; Choi J; Jones S; Ghebranious N; Igelmann H; Lu X; Soron G; Cooper B; Brayton C; Park SH; Thompson T; Karsenty G; Bradley A; Donehower LA
    Nature; 2002 Jan; 415(6867):45-53. PubMed ID: 11780111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53, p21(WAF1/CIP1), and MDM2 involvement in proliferation and apoptosis in an in vitro model of conditionally immortalized human vascular smooth muscle cells.
    Hsieh JK; Kletsas D; Clunn G; Hughes AD; Schachter M; Demoliou-Mason C
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):636-44. PubMed ID: 10712385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor dosage regulates stem cell dynamics during aging.
    Gatza C; Moore L; Dumble M; Donehower LA
    Cell Cycle; 2007 Jan; 6(1):52-5. PubMed ID: 17245110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JunD protects cells from p53-dependent senescence and apoptosis.
    Weitzman JB; Fiette L; Matsuo K; Yaniv M
    Mol Cell; 2000 Nov; 6(5):1109-19. PubMed ID: 11106750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of p53-46F as a super p53 with an enhanced ability to induce p53-dependent apoptosis.
    Nakamura Y; Futamura M; Kamino H; Yoshida K; Nakamura Y; Arakawa H
    Cancer Sci; 2006 Jul; 97(7):633-41. PubMed ID: 16827804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.